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Human NK cells kill resting but not activated microglia via
NKG2D- and NKp46-mediated recognition
Abstract
Microglia are resident macrophage-like APCs of the CNS. To avoid escalation of inflammatory
processes and bystander damage within the CNS, microglia-driven inflammatory responses need to be
tightly regulated and both spatially and temporally restricted. Following traumatic, infectious, and
autoimmune-mediated brain injury, NK cells have been found in the CNS, but the functional
significance of NK cell recruitment and their mechanisms of action during brain inflammation are not
well understood. In this study, we investigated whether and by which mechanisms human NK cells
might edit resting and activated human microglial cells via killing in vitro. IL-2-activated NK cells
efficiently killed both resting allogeneic and autologous microglia in a cell-contact-dependent manner.
Activated NK cells rapidly formed synapses with human microglial cells in which perforin had been
polarized to the cellular interface. Ab-mediated NKG2D and NKp46 blockade completely prevented the
killing of human microglia by activated NK cells. Up-regulation of MHC class I surface expression by
TLR4 stimulation protected microglia from NK cell-mediated killing, whereas MHC class I blockade
enhanced cytotoxic NK cell activity. These data suggest that brain-infiltrating NK cells might restrict
innate and adaptive immune responses within the human CNS via elimination of resting microglia.
Human NK Cells Kill Resting but Not Activated Microglia via
NKG2D- and NKp46-Mediated Recognition1
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Microglia are resident macrophage-like APCs of the CNS. To avoid escalation of inflammatory processes and bystander damage
within the CNS, microglia-driven inflammatory responses need to be tightly regulated and both spatially and temporally re-
stricted. Following traumatic, infectious, and autoimmune-mediated brain injury, NK cells have been found in the CNS, but the
functional significance of NK cell recruitment and their mechanisms of action during brain inflammation are not well understood.
In this study, we investigated whether and by which mechanisms human NK cells might edit resting and activated human
microglial cells via killing in vitro. IL-2-activated NK cells efficiently killed both resting allogeneic and autologous microglia in a
cell-contact-dependent manner. Activated NK cells rapidly formed synapses with human microglial cells in which perforin had
been polarized to the cellular interface. Ab-mediated NKG2D and NKp46 blockade completely prevented the killing of human
microglia by activated NK cells. Up-regulation of MHC class I surface expression by TLR4 stimulation protected microglia from
NK cell-mediated killing, whereas MHC class I blockade enhanced cytotoxic NK cell activity. These data suggest that brain-
infiltrating NK cells might restrict innate and adaptive immune responses within the human CNS via elimination of resting
microglia. The Journal of Immunology, 2008, 181: 6170–6177.
M icroglia (MG)3 are an integral part of the resident mono-nuclear phagocyte population in the CNS and sharemany phenotypic and functional characteristics with
other tissue macrophages and peripheral blood monocytes (1). Any
type of injury or pathological process within the CNS leads to acti-
vation of these cells from their resting state (2). Subsequent to acti-
vation, microglial cells produce proinflammatory cytokines, such as
TNF-, IL-6, and IL-12, and acquire the ability to process Ags for
presentation to infiltrating T cells on up-regulated MHC class I and
class II molecules in conjunction with costimulatory molecules (3).
To avoid escalation of inflammatory processes and bystander damage
within the CNS, MG-driven inflammatory responses need to be
tightly regulated and both spatially and temporally restricted (3–5).
NK cells have been suggested to edit human myeloid cells during
immune responses via cytotoxic activity (6, 7). This NK cell effector
function is controlled by germline-encoded activating and inhibitory
receptors on these innate lymphocytes. Only if more activating signals
are received due to high expression of activating NK cell receptor
ligands or loss of inhibitory NK cell receptor ligands, NK cell killing
is unleashed. The main activating NK cell receptors are NKG2D, the
natural cytotoxicity receptors NKp30, NKp44, and NKp46 and
DNAM-1. The ligands for these activating receptors are primarily
up-regulated upon cellular stress, like during viral infections or trans-
formation (8, 9). As inhibitory structures, MHC class I molecules are
primarily recognized by killer Ig-like receptors or CD94/NKG2A (8,
9). Therefore, stressed cells with down-regulated MHC class I mol-
ecules are preferentially targeted by NK cells.
The immune privilege of the CNS is thought to be maintained
by endothelial tight junctions of the blood-brain barrier (BBB) and
the presence of an immunosuppressive microenvironment (10).
BBB disruption leads to recruitment of a large number of leuko-
cytes into the CNS, among which NK cells have been shown to
accumulate in the CNS following traumatic peripheral axotomy
(11–13) and in the course of infectious as well as autoimmune
CNS inflammation (14–17). Whereas the frequency of CNS-infil-
trating NK cells in acute and chronic neuroinflammatory diseases
in humans has so far not been thoroughly characterized, it was
estimated that NK cells comprise 10–20% of CNS infiltrates in
experimental autoimmune encephalomyelitis (EAE) models (15,
16). However, the functional significance of NK cell recruitment
and their mechanism of action during brain inflammation are not
well understood. To address a possible immunoregulatory function
of NK cells within the inflamed human CNS, we investigated NK
cell interactions with resting and activated human MG.
Materials and Methods
Primary human microglia cell culture
Second trimester fetal brain tissue was obtained under institutional review
board-approved protocols from the fetal tissue repository at the Albert
Einstein College of Medicine (New York, NY) or ABR (Alameda, CA).
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Mixed human fetal CNS cell cultures were prepared by enzymatic and
mechanical dissociation of the cerebral tissues followed by filtration
through nylon meshes of 250- and 130-m pore sizes, as described pre-
viously (18). Cells were plated at 106–107 cells/ml in DMEM (supple-
mented with 4.5 g/L glucose, 4 mM L-glutamine, and 25 mM HEPES;
L-tryptophan concentration, 16 g/ml; Cellgro) plus 5% FCS (Gemini Bio-
Products), penicillin (100 U/ml), streptomycin (100 g/ml), and ampho-
tericin B (0.25 g/ml; Fungizone) for 2 wk. Briefly, highly enriched cul-
tures of human fetal MG (98% CD11b cells as determined by flow
cytometry, compared with respective isotype control) were generated by
gentle collection of floating cells in confluent monolayer cultures consist-
ing of astrocytes, neurons, and MG at 2–3 wk in vitro. Cells were seeded
in low cell-binding 24-well-plates (Nunc) at 250,000 cells/well. In some
experiments, microglia were preactivated for 48 h with 100 or 200 ng/ml
LPS from Salmonella minnesota (Sigma-Aldrich).
Generation of macrophages and dendritic cells (DCs)
PBMCs were isolated from leukocyte concentrates (New York Blood Bank)
by density gradient centrifugation (Ficoll-Paque Plus; Amersham Pharmacia
Biotech.). Serum was collected, heat inactivated for 30 min at 56°C, and fil-
tered. Monocytes were isolated by magnetic CD14 selection (MACS; Milte-
nyi Biotec). Monocytes were cultured as described previously (19) in X-vivo
medium with 1% autologous serum for 10–12 days to generate macrophages.
For activation, macrophages were incubated with 100 ng/ml LPS from S. min-
nesota (Sigma-Aldrich) for 48 h. Immature DCs were generated according to
standard protocol (20). Briefly, CD14 cells were cultured for 5 days in RPMI
1640, 1% heat-inactivated human Ab serum (Cellgro), gentamicin, IL-4, and
GM-CSF. Where indicated, DCs were matured with 25 g/ml poly(I:C)
(InvivoGen) or 100 ng/ml LPS (Sigma-Aldrich) for 48 h.
Isolation of NK cells
NK cells were isolated by negative selection using the NK cell Isolation Kit II
(Miltenyi Biotec) according to the manufacturer’s instructions. The purity of
the isolated B cells and NK cells was higher than 90% and contained 5%
contaminating T cells as determined by flow cytometry. Separated NK cells
were activated with 100 U/ml IL-2 for 5 days before coculture. IL-2 was used
as a classical NK cell mitogen, which could be produced by activated T cells
which constitute a major component of inflammatory CNS infiltrates (21).
IFN- production assay
For intracellular staining of IFN-, activated NK cells were incubated with
PKH26-labeled MG at a ratio of 10:1 at 37°C in RPMI 1640 plus 5%
human serum plus gentamicin. Brefeldin A was added after 1 h of coculture
and an additional 5 h later cells were harvested and stained with Aqua
Live/Dead Cell stain (Invitrogen) according to the manufacturer’s protocol.
After fixing the cells with 2% paraformaldehyde, they were permeabilized
and stained with fluorochrome-labeled anti-IFN-. PKH26, live, small
cells were analyzed using FlowJo software (Tree Star).
Flow cytometry analysis
Microglia were stained with fluorochrome-labeled Abs specific for CD11b
(M1/70; BD Biosciences), MHC class I HLA-A,B,C (W6/32; BioLegend),
poliovirus receptor (CD155; MBL), and their respective isotype controls for 30
min at 4°C. The unlabeled Nectin-2-specific Ab (Santa Cruz Biotechnology)
was followed by an incubation with a fluorochrome-labeled secondary anti-
mouse IgG Ab (BD Biosciences) for 30 min at 4°C. For NKG2D ligand stain-
ing, biotinylated NKG2D monomers were provided by A. Steinle (University
of Tu¨bingen, Tu¨bingen, Germany) and tetramerized as previously described
for MHC class I tetramers (22). HLA-A2/HIV gag peptide tetramers served as
a control for NKG2D tetramer staining of NKG2D ligands. After two washes,
cells were resuspended in 200l of PBS. At least 30,000 events were collected
on a BD Biosciences LSR II flow cytometer. Frequencies were calculated
using FlowJo software (Tree Star).
TO-PRO3 iodide (TP3) cytotoxicity assay
Cytotoxicity of NK cells was quantified using the previously described flow
cytometry-based TP3 (Invitrogen) assay (23). It has to be noted that this assay
might underestimate the total number of dead cells, since the frequency of
dying cells in this assay is based on the forward scatter/side scatter live cell
gate rather than on release of chromium 51. A number of previous studies
have, however, shown that cytotoxicity measured by the flow cytometric cell-
mediated cytotoxicity assay correlates well with the conventional chromium
51 release assay and the PKH-26/TP3-based assay is now widely used as a
reproducible experimental system for NK cell and Ab-dependent cell-medi-
ated cytotoxicity (23–26). Briefly, human microglial cells, macrophages, or
DCs were labeled with a membrane dye, PKH-26, to allow discrimination of
target cells after incubation with effector cells. Postincubation, cell death
within the PKH-26 target cell population was assessed by the addition of the
viability probe TP3 (Invitrogen). Flow cytometry data were acquired on a BD
Biosciences LSRII flow cytometer and analyzed with FlowJo software (Tree
Star). This method allows analysis to be conducted on a single-cell basis and
overcomes the need for radioactive chemicals. For neutralization experiments,
NK cells were preincubated for 1 h at 37°C with a 10 g/ml Ab concentration.
The blocking Abs, NKG2D (BAT221), NKp30 (F252), and NKp46 (KL247)
were gifts from Drs. A. Moretta (University of Genoa, Genoa, Italy) and Guido
FIGURE 1. NK cells kill human MG. Fetal human microglial cells were cocultured with allogeneic (upper panel) or autologous (lower panel) IL-2-
activated NK cells for 4 h. The extent of cytotoxicity was quantified by the relative number of live human MG cells labeled with PKH-26 and dead, permeabilized
cells labeled with both PKH-26 and TP3. A and E, Spontaneous permeabilization of primary human MG. B, C, F, and G, Permeabilization at different E:T ratios.
D and H, Diagrams summarize at least three experiments and display means and SEM of TP3 MG cells compared with PKH26 MG cells after coculture with
increasing E:T ratios. D, MG vs 10:1: , p  0.0001 for E:T ratio of 10:1. H, MG vs 10:1: , p  0.0492 for E:T ratio of 10:1.
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Ferlazzo (University of Messina, Messina, Italy). In addition, MHC class I Ab
(W6/32; BioLegend), DNAM-1 (mAb 666; R&D Systems), LFA-1 (CD11a;
BioLegend), and 2B4 (CD244; Beckman Coulter) were used. Expression of
ligands for the latter two molecules (ICAM-1 and CD48, respectively) by
microglial cells could previously be demonstrated (27–29).
Conjugation of human MG with NK cells
For conjugation assays, resting or IL-2-activated NK cells were cocultured
with MG. Cells were mixed at a NK cell:MG ratio of 1:1 in 20 l of RPMI
1640 without serum before being pelleted at 10,000  g. The pellets were
allowed to conjugate for 1 min at 37°C. After initial conjugation, cells were
gently resuspended and centrifuged onto poly-lysine-coated 1.5-mm cov-
erslips for immunofluorescence analysis. Cells on slides were fixed in 3%
paraformaldehyde for 20 min at 4°C. Cells were permeabilized with 0.01%
Triton X-100 for 1 min at room temperature and stained with anti-talin
(TD77) or anti-perforin (G9) Abs (Chemicon International), followed by
Alexa Fluor 555-conjugated rabbit anti-mouse IgG Ab (Invitrogen). Con-
trol Abs used were mouse IgG1 (MOPC-21; BioLegend) and mouse
IgG2b, (MOPC-141; Sigma-Aldrich). All washes were performed in PBS
supplemented with 1% fish skin gelatin (Sigma-Aldrich) and 0.02% saponin
(Sigma-Aldrich). Slides were counterstained with 4,6-diamidino-2-phe-
nylindole and mounted with Prolong gold antifade reagent (Invitrogen) and
visualized with an inverted Olympus IX-70 microscope (DeltaVision Mi-
croscope; Applied Precision/Olympus) and a Photometrics CoolSnap QE
camera. Serial optical sections (0.2 m; 20 sections) were acquired for all
labelings. Images were then deconvoluted using DeltaVision SoftWoRx
software version 3.4.4, and photographs were overlaid using Metamorph
software version 6.3r6 (Universal Imaging). Molecules at the synapse were
quantified with ImageJ software. The enrichment of talin at the contact site
of each conjugate was measured and compared with the distribution of
the same molecule in a similar area opposite to the contact site within the same
cell. The relative enrichment (RE) was calculated as the average inten-
sity per volume unit at the contact site or in an equivalent volume
opposite to the contact site divided by the average intensity per unit
volume of the entire cell. The area of the contact site was defined
manually and represented 16.8  4.2% of the total cell volume. The
area across the contact site was defined manually and represented
17.2  4.4% of the total cell volume. The values obtained in uncon-
jugated cells were considered as baseline, and data represent the ratio of
RE at the contact site to RE at an equivalent volume opposite from the
contact site normalized to the values in single cells, assigned as 100%.
The percentage of conjugates showing perforin polarization was as-
sessed in randomly selected fields after the analysis of at least 500
conjugates per experiment.
Statistics
Statistical analyses were performed with the Student t test using GraphPad
Prism software. A p  0.05 was considered significant. Plotted data are
displayed as mean with SEM.
Results
Activated NK cells kill allogeneic and autologous human MG in
a cell contact-dependent manner
To determine whether human microglial cells are susceptible to
NK cell-mediated cell editing by killing, we performed a flow
FIGURE 2. NK cells produce IFN- upon recognition of MG. IL-2-acti-
vated NK cells were cocultured with MG in an E:T ratio of 10:1, as for the
cytotoxicity assay. Intracellular staining for IFN- was performed after 6 h of
coculture. The frequency of IFN- producing activated NK cells was 6.5-fold
higher following MG compared with nontarget cell recognition (mean fre-
quency SEM of IFN- producing IL-2-activated NK cells in MG cocultures
vs IL-2-activated NK cells alone: 0.31  0.1 vs 0.05  0.02; p  0.02).
Representative and summarized data of four experiments are shown.
FIGURE 3. Synapse formation and perforin polarization in NK cell-MG conjugates. Polarization of the cytoskeletal protein talin, indicative of synapse
formation, and of the cytotoxic molecule perforin in NK cells was determined by two-dimensional immunofluorescence microscopy after 1 min. A, Perforin
and talin polarization in IL-2-activated NK cells conjugated to MG. B, Perforin is polarized in conjugates of MG with IL-2-activated NK cells. Nonpolarized
vs polarized perforin in conjugates with resting NK cells: , p  0.001; nonpolarized vs polarized perforin in conjugates with activated NK cells:
, p  0.0001. C, RE of talin to cell contact areas in NK cell conjugates with MG compared with NK cells alone. Resting NK cells alone vs
conjugated: , p  0.0001; activated NK cells alone vs conjugated: , p  0.0001; Student’s t test. Representative and summarized data for
three experiments are shown. DIC, Differential interference contrast.
6172 NK CELL CYTOTOXICITY TOWARD MG
cytometry-based cytotoxicity assay using the fluorophores
PKH-26 to label MG and the DNA intercalating dye TP3 to de-
termine the viability of PHK-26 target cells. The extent of cyto-
toxicity was quantified by the relative number of live human mi-
croglial cells labeled with PKH-26 and dead, permeabilized cells
labeled with both PKH-26 and TP3 (23). As shown in Fig. 1,
IL-2-activated NK cells efficiently killed microglial cells at E:T
ratios of 10:1 after 4 h of incubation. Although the relative con-
tribution of microglial cells and NK cells to the total cell number
within CNS lesions associated with BBB disruption has so far not
been characterized, we propose that such an E:T ratio might be
specifically relevant during acute CNS inflammation during which
NK cells comprise 10–20% of CNS cellular infiltrates (15, 16). In
addition, MG cell recognition was associated with induction of
IFN- production (Fig. 2) by activated NK cells, indicating that
MG triggers both NK cell cytokine production and cytotoxic ac-
tivity. MG cells, cocultured with autologous NK cells isolated
from fetal liver tissue, were killed at similar levels as allogeneic
target cells (Fig. 1), suggesting that the MHC class I polymor-
phism at the low constitutive expression levels on microglial cells
modifies NK cell killing only to a low extent. To assess the de-
pendency on soluble factors as opposed to direct cell-cell contact
on microglial cell cytotoxicity, we next quantified NK cell cyto-
toxic activity in Transwell vs non-Transwell cocultures. As shown
in Fig. 2, the frequency of TP3 MG cells in Transwell cultures at
E:T ratios of 10:1 was similar to spontaneous microglial cytotox-
icity, demonstrating that NK cell killing of human MG was pri-
marily cell contact dependent. These results suggested that resting
MG could be killed by activated NK cells.
Rapid synapse formation and perforin polarization in NK
cell-MG conjugates
To further analyze the cell contact dependency of MG killing by
NK cells, we determined the formation and kinetics of cell-cell
contact interactions between NK cells and microglial cells in vitro.
For this purpose, we analyzed the polarization of the cytoskeletal
protein talin, indicative of synapse formation, and of perforin, a
pore-forming molecule of cytotoxic lymphocytes, in NK cells by
two-dimensional immunofluorescence microscopy after 1 min. As
shown in Fig. 3, talin was evenly distributed at the cell surface in
FIGURE 4. Killing of human MG by NK cells is dependent on cell contact and NKG2D and NKp46. MG cells were cocultured with purified and
IL-2-activated NK cells for 4 h at an E:T ratio of 10:1. Specific cell lysis was quantified by TP3 staining. Shown are means and SEM of TP3 MG cells
compared with PKH26 MG cells. A, Coculture was performed using Transwell (TR) and non-Transwell (N-TR) plates. , p  0.0492. B, NK cells were
preincubated for 1 h without Abs, with IgM and IgG isotype control Abs, anti-NKp30, anti-NKp46, or anti-NKG2D Ab. NK:MG 10:1, IgG1 vs NKG2D:
, p 0.0009; NK:MG 10:1, IgM vs NKp46: , p 0.03. C, NK cells were preincubated for 1 h with IgG isotype control Abs, anti-DNAM-1, anti-LFA-1,
or anti-2B4 Ab: , p  0.0073. Three experiments are summarized.
FIGURE 5. MHC class I blockade
enhances NK cell cytotoxicity toward
human MG. MG cells were cocultured
with purified and IL-2-activated NK
cells for 4 h in the presence and absence
of a monoclonal-blocking MHC class I-
specific Ab or an isotype control. Spe-
cific cell lysis was quantified by TP3
staining. The diagram displays means
and SEM of TP3 MG cells compared
with PKH26 MG cells after coculture.
MHC class I vs IgG1: , p  0.0171.
Representative data for three experi-
ments are shown.
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unconjugated, resting, and activated NK cells. In MG/NK cell con-
jugates, talin was enriched at the cell contact area compared with
the opposite side from the interface between MG and NK cells (RE
mean  SEM: 169.2  4.5% in resting NK cells and 230.2 
5.9% in activated NK cells, respectively). The percentage of con-
jugates showing perforin polarization was assessed after the anal-
ysis of at least 500 conjugates per experiment in randomly selected
fields. When resting NK cells formed conjugates with MG, 31.4
4.7% (mean  SEM) of conjugates recruited perforin to the con-
tact area within 1 min of coculture (Fig. 3B) compared with 67.2
2.7% (mean  SEM) when activated NK cells formed conjugates
with MG. These data indicated that NK cells rapidly formed im-
munological synapses with human microglial cells and that the
cytotoxic molecule perforin was rapidly polarized to the interface
between MG and NK cells.
NK cell-mediated cytotoxicity toward human MG is NKG2D-
and NKp46-dependent and enhanced by MHC class I blockade
Because the NK-mediated killing of tumor as well as normal cells
can utilize a number of activating NK cell receptors, we analyzed
whether mAb-mediated masking of some of these receptors could
affect NK cell cytotoxicity against microglial cells. As shown in
Fig. 4, the addition of anti-NKp30 mAb as well as the isotype
control Ab had no effect on cytotoxicity. In contrast, a marked
inhibition was detected upon addition of anti-NKp46 mAb and
NK-mediated cytotoxicity was virtually abrogated following
blockade of the activating NKG2D receptor. DNAM-1-, LFA-1-,
and 2B4-specific monoclonal-blocking Abs had no effect on NK
cell-mediated lysis of human microglial cells (Fig. 4C). The ob-
servation that cell contact-dependent NK cell killing of MG is not
inhibited by LFA-1 blockade indicates a certain level of redun-
dancy of adhesion molecules in mediating synapse formation be-
tween the two cell types (30). Moreover, in contrast to immature
DCs, which are killed via NKp30, NKp46, and DNAM-1-mediated
recognition (31–33) but similar to macrophages which have been
found to be susceptible to NKG2D-dependent cytotoxicity by NK
cells (19), our data indicate that MG cell lysis by NK cells is spe-
cifically dependent on NKG2D- and NKp46-mediated recognition.
We also demonstrated that blockade of the MHC class I mole-
cules, HLA-A,B,C, enhanced NK cell-mediated cell cytotoxicity,
indicating that the modest MHC class I expression of MG, never-
theless, inhibited NK cell killing to some extent (Fig. 5). These
data indicated that the opposing activating and inhibitory signals,
involved in NK cell recognition of MG, were mediated by the
FIGURE 6. Surface expression of ligands for activating NK cell recep-
tors, i.e., NKG2D and DNAM-1, on resting and activated microglial cells.
NKG2D ligands were constitutively expressed on human microglial cells
in vitro and down-regulated following LPS stimulation (p  0.0005) (A).
MG also constitutively expressed DNAM-1 ligands, poliovirus receptor
(PVR; B) and Nectin-2 (C), whose expression remained unchanged fol-
lowing LPS stimulation. Summarized data from three experiments are
shown.
FIGURE 7. TLR ligation on human MG by LPS
protected microglial cells from NK cell-mediated
cytotoxicity (A); , p 0.02. In contrast, monocyte-
derived macrophages were more susceptible to NK
cell-mediated cell lysis following LPS stimulation
(C), , p  0.004, whereas matured DCs were less
susceptible (B), , p  0.001. In addition, LPS
stimulation resulted in an up-regulation of MHC
class I surface expression on microglial cells and the
protective effect of MG activation could be reversed
by MHC class I blockade, , p  0.002, indicating
that this effect was primarily MHC class I mediated
(D). At least three experiments for each cell type are
summarized.
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activating NK cell receptors NKG2D and NKp46 on one side and
MHC class I-binding receptors on the other.
Activated MG are protected from NK cell-mediated cytotoxicity
MG are resident macrophage-like cells of the CNS and recognize
the presence of pathogens in part via TLR that detect ligands on
bacterial, viral, and fungal pathogens. Since TLR signaling in mac-
rophages has been shown to induce NKG2D ligand expression
(34) and since TLR-mediated activation of monocyte-derived mac-
rophages is reported to be associated with an increased suscepti-
bility toward NK cell-mediated cytotoxicity (19), we investigated
whether TLR ligation interfered with the expression of ligands for
activating NK cell receptors, i.e., NKG2D and DNAM-1, and the
susceptibility of MG cells toward NK cell cytotoxicity.
Using tetrameric NKG2D, we found that NKG2D ligands are
constitutively expressed on human microglial cells in vitro and
were down-regulated following LPS stimulation (Fig. 6A). MG
also constitutively expressed DNAM-1 ligands, i.e., poliovirus re-
ceptor and Nectin-2, whose expression remained, however, un-
changed following LPS stimulation (Fig. 6, B and C).
TLR ligation on human MG by LPS protected microglial cells
as well as matured monocyte-derived DCs from NK cell-mediated
cytotoxicity (Fig. 7, A and B). In contrast, monocyte-derived mac-
rophages were more susceptible to NK cell-mediated cell lysis
following LPS stimulation (Fig. 7C), indicating a functional dif-
ference of resting and activated primary MG compared with mono-
cyte-derived macrophages. LPS stimulation resulted in an up-reg-
ulation of MHC class I surface expression on microglial cells and
the protective effect of MG activation could be reversed by MHC
class I blockade, indicating that this effect was primarily MHC
class I-mediated (Fig. 7D). Altogether, these data suggested that
activated MG, in contrast to macrophages, were less susceptible to
NK cell-mediated cytotoxicity and that activation of MG was as-
sociated with expression of more inhibitory than activating ligands
for NK cell receptors.
Discussion
Our study has shown that human microglial cells were susceptible
to allogeneic and autologous NK cell editing by cytotoxicity. NK
cells rapidly formed synapses with human MG cells, in which the
cytotoxic molecule perforin was polarized to the cell contact area.
Killing of MG was dependent on NKG2D and NKp46 engagement
and counterbalanced by MHC class I binding inhibitory NK cell
receptors. Microglial activation by TLR ligation was associated
with up-regulation of MHC class I molecules and thereby inhibited
NK cell-mediated killing of human MG. These data suggest that
brain-infiltrating NK cells might have the capacity, via elimination
of resting MG cells, to negatively regulate the afferent limb of
innate and adaptive immune responses within the human CNS.
Because of the lack of mouse strains that are selectively defi-
cient in NK cells, the study of NK cell function in vivo has been
challenging in the past (35) and animal models of acute inflam-
matory CNS diseases provided evidence for both disease acceler-
ating and protective effects of NK cells (17, 36–39). It has been
suggested that NK cells could be pathogenic by shaping Th1-po-
larized adaptive immune responses, by activating CNS-infiltrating
DCs, and/or via direct recognition and lysis of inflammation-acti-
vated brain cells (39, 40). However, most EAE studies reported
that NK cells protect from autoimmune-mediated tissue damage,
presumably by editing initiator and effector cell populations (15,
16, 37, 41).
Several cell types of the human lymphoid and myeloid lineages
have been suggested as targets of autologous NK cell cytotoxicity.
T cells have been shown to up-regulate NKG2D ligands following
activation and to become susceptible to autologous NK cell-me-
diated cell lysis in vitro (26, 42, 43). Lu et al. (41) demonstrated
that the interaction between the mouse homolog of the human
MHC class Ib molecule HLA-E, Qa-1-Qdm, on activated T cells
and CD94-NKG2A inhibitory NK cell receptors, protects activated
CD4 T cells from perforin-mediated NK cell cytotoxicity. Ab-
dependent blockade of this Qa-1-NKG2A interaction resulted in
potent NK-dependent elimination of activated autoreactive T cells
and amelioration of EAE in MOG35–55 immunized C57BL/6 mice
(41). HLA-E-NKG2A as well as classical MHC class I ligand-
killer Ig-like receptor interactions have also been proposed to be
involved in the protection of mature DCs from autologous NK
cell-mediated killing (44). In addition, activated NK cells can kill
autologous immature myeloid DCs via NKp30,- NKp46-, and
DNAM-1-mediated recognition (31–33, 45–49) and, similar to
MG, pathogen infection, TLR ligation, or stimulation by proin-
flammatory cytokines protect DCs from NK cell-mediated cyto-
toxicity, presumably via increased surface expression of MHC
class I molecules (44–46, 48–50).
In contrast to DCs, monocyte-derived macrophages are resistant
to autologous NK cell cytotoxicity unless they become activated
and express NKG2D ligands (NKG2DL) by high doses of LPS
(200 ng/ml) (19). Consequently, NK cell-mediated cytotoxicity of
LPS-stimulated macrophages was abrogated by an anti-NKG2D
mAb (19). Although these data indicate that the stimulatory signal
resulting from NKG2D-NKG2DL interactions overcomes the in-
hibitory signal provided by MHC class I ligands on activated mac-
rophages, we observed that microglia stimulated with a high dose
of LPS (200 ng/ml) were less susceptible to NK cell-mediated
cytotoxicity. Thus, similar to immature and mature DCs, resting
MG were susceptible to NK cell-mediated cytotoxicity while mi-
croglial activation protected these CNS resident APCs from being
killed by NK cells. By this mechanism, NK cells might reduce the
microglial pool, but allow fully activated microglial cells to
present Ags to infiltrating T cells and to initiate a limited immune
response in the brain.
Investigating the interface between CD8 T cells, NK cells and
oligodendrocytes as a potential mechanisms of immune-mediated
tissue injury in multiple sclerosis, Saikali et al. (51) also addressed
the susceptibility of fetal brain-derived MG cells toward cell lysis
by NK cells. Studying two CNS cell samples, they reported that
IL-2-activated NK cells efficiently lyse nonactivated allogeneic
MG, but did not find any differences between samples treated with
and without NKG2D-specific blocking Abs. In contrast, we found
that MG killing by NK cells is substantially and reproducibly in-
hibited by NKG2D blockade. These differences might be ex-
plained by using different clones for Ab-mediated blockade of
NKG2D recognition.
Although our findings are compatible with the aggravating effect
of NK cell depletion in autoimmune CNS inflammation (15, 37,
41, 52), they do not exclude the possibility that CNS-invading NK
cells might display unwanted cytotoxic activity against neuronal
cells, oligodendrocytes, or astrocytes. However, experimental data
on the interactions between NK cells and CNS resident cells are
both scarce and controversial. Oligodendrocytes have been re-
ported to be either susceptible (40, 51) or not (53, 54) toward
IL-2-activated NK cell killing. CNS neurons appear to be resistant
to NK cell cytotoxicity (55, 56), and Hammarberg et al. (12) re-
ported that CNS-infiltrating NK cells produce high levels of neu-
rotrophic factors, such as brain-derived neurotrophic factor and
neurotrophin-3, which protected embryonic motor neuron cultures
from TNF-- or IFN--mediated neuronal cell injury.
In conclusion, we found that NK cells were capable of targeting
human MG. These findings extend the functional reach of the NK
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system to include the regulation of CNS intrinsic immune re-
sponses. Together with the reported cytotoxic activity of NK cells
toward activated T cells, activated macrophages, and immature
DCs, our study adds to the evidence for NK cells as immunoedit-
ing lymphocytes involved in the shaping of adaptive immunity
beyond their already described polarizing activity via cytokine se-
cretion (57). The mechanism, identified in our experiments might
be involved in limiting neuroinflammation associated with BBB
disruption and NK cell recruitment into the CNS. Although much
has yet to be learned about the function of NK cells during infec-
tious and autoimmune CNS diseases, these data suggest that ther-
apeutic targeting of NK cells or NK cell subsets during CNS
inflammation (16) might have clinical merit.
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